Submit Manuscript  

Article Details


Anticancer Drug Development, System Updating and Global Participations

[ Vol. 12 , Issue. 1 ]

Author(s):

Da-Yong Lu*, Ting-Ren Lu, En-Hong Chen, Nagendra Sastry Yarla, Bin Xu, Jian Ding and Hong Zhu   Pages 37 - 45 ( 9 )

Abstract:


Background: New anticancer drug discovery, development and manufacture entered the bottleneck stage. Many limitations of both technology and animal models slow down the anticancer drug developments

Objective: To ease economic burdens for drug developers and general patient populations.

Methods: Key factors affecting anticancer drug developments and possible roadmaps for updating drug screening routines worldwide are suggested.

Results: Drug development chains must be updated and better drug development paradigms must be established.

Conclusions: This world welcomes global participations in anticancer drug developments and utilities.

Keywords:

Anticancer drug development, neoplasm metastasis, cost-effective, medicinal chemistry, animal models, drug toxicity, cancer stem cells, individualized cancer therapy.

Affiliation:

School of Life Sciences, Shanghai University, Shanghai 200444, College of Science, Shanghai University, Shanghai 200444, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, GITAM University, Viskhatnam, AP, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, Zhejiang University, Hangzhou

Graphical Abstract:



Read Full-Text article